2022 Stronger - PH317 - Advancing Antimicrobial Stewardship for the Future - On Demand
This session features a panel of health care leaders who will share their experiences surrounding the benefits and importance of advanced antimicrobial stewardship programs.
After observing a surgical site infection (SSI) increase in certain orthopedic procedures, AtlantiCare Regional Medical Center’s Antimicrobial Stewardship Program modified its existing surgical prophylaxis protocol by adding gentamicin to reduce the postoperative infection rate — successfully reducing the rate of SSI occurrence.
The centralized Antimicrobial and Diagnostic Advisement Program at Saint Luke’s Health System leads diagnostic stewardship efforts. The organization successfully navigated diagnostic challenges by hosting a diagnostic stewardship summit, informing other health systems how embracing diagnostics optimizes long-term fiscal and clinical gains.
Alta Hospitals established a multihospital, centralized antibiotic stewardship program (ASP) among five acute care and three subacute care community facilities. Within two years of its inception, this centralized ASP transformed the hospital facilities from having minimal ASP oversight to achieving the California Department of Public Health Antimicrobial Stewardship Program Honor Roll.
Join this session to hear great insights to help advance antimicrobial stewardship at your organization.
- Other Healthcare Professionals
Identify the major pathogens associated with postoperative orthopedic surgeries.
Discuss the methods employed to ensure proper antibiotics are used for surgical prophylaxis in orthopedic procedures.
Outline strategies to engage multidisciplinary and leadership teams in the redeployment of a diagnostic testing application — leveraging the skills and knowledge of the antimicrobial stewardship program and microbiology department.
Identify the implementation, engagement and savings of a multi-facility, centralized, antibiotic stewardship program in a community health system.
Joseph Reilly, PharmD, Pharmacist, AtlantiCare Regional Medical Center, Pomona, NJ
Nick Bennett, PharmD, BCIDP, Manager, Antimicrobial & Diagnostic Advisement Program, Saint Luke's Health System, Kansas City, MO
Sarah Boyd, MD, Medical Director, Antimicrobial & Diagnostic Advisement Program, Saint Luke's Health System, Kansas City, MO
Cindy (Mei Xian) Hsieh, PharmD, BCPS, BCIDP, Clinical Pharmacy Specialist – Infectious Diseases, Alta Hospitals System, Los Angeles, CA
Sehjan Bhura, PharmD, Chief Pharmacy Officer, Prospect Medical Holdings, Los Angeles, CA
Interprofessional Continuing Education (IPCE)
This activity was planned by, and for, the healthcare team, and learners will receive 0.75 Interprofessional Continuing Education (IPCE) credits for learning and change.
Vizient, Inc. designates this enduring material for a maximum of 0.75 contact hours for Pharmacists.
Universal Activity Number: JA0006103-0000-22-090-H01-P
Vizient, Inc. designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Other Healthcare Professionals (General CE Credit)
Vizient, Inc. will award a maximum of 0.75 contact hours to all other healthcare professionals who successfully complete the activity. These individuals will receive a Certificate of Participation indicating the maximum credits available.
Many state licensing boards and credentialing bodies accept certificates of participation from accredited CE activities to meet CE requirements for license renewals and re-certification. It is the responsibility of the participant to contact their state licensing board and/or certifying body for verification on credit eligibility reciprocity.
- 0.75 ACPE Pharmacist
- 0.75 AMA PRA Category 1 Credit™
- 0.75 General CE – Attendance
- 0.75 Interprofessional Continuing Education (IPCE)